Ligand Pharmaceuticals Director Unloads 2,501 Shares — Should You Be Concerned?
Director John W. Kozarich reported the sale of 2,501 shares of Ligand Pharmaceuticals (LGND +0.38%) in open-market transactions from May 1, 2026 through May 13, 2026, according to a SEC Form 4 filing. Transaction summary Metric Value Shares traded (direct …